Susquehanna International Group
ALT icon

Susquehanna International Group’s Altimmune ALT Stock Holding History

Susquehanna International Group’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.73M Buy
561,400
+20,100
+4% +$85.3K ﹤0.01% 6517
2025
Q4 		$1.95M Sell
541,300
-284,700
-34% -$1.24M ﹤0.01% 5707
2025
Q3 		$3.11M Sell
826,000
-291,900
-26% -$1.13M ﹤0.01% 4910
2025
Q2 		$4.33M Buy
1,117,900
+969,400
+653% +$5.25M ﹤0.01% 4251
2025
Q1 		$743K Sell
148,500
-555,900
-79% -$3.52M ﹤0.01% 8007
2024
Q4 		$5.08M Buy
704,400
+360,900
+105% +$2.76M ﹤0.01% 3561
2024
Q3 		$2.11M Sell
343,500
-151,500
-31% -$1.03M ﹤0.01% 5169
2024
Q2 		$3.29M Sell
495,000
-97,100
-16% -$717K ﹤0.01% 4140
2024
Q1 		$6.03M Sell
592,100
-306,800
-34% -$3.12M ﹤0.01% 3337
2023
Q4 		$10.1M Buy
898,900
+624,200
+227% +$2.61M ﹤0.01% 2633
2023
Q3 		$714K Buy
274,700
+176,400
+179% +$506K ﹤0.01% 7399
2023
Q2 		$347K Sell
98,300
-99,000
-50% -$444K ﹤0.01% 9145
2023
Q1 		$833K Sell
197,300
-231,200
-54% -$2.75M ﹤0.01% 7305
2022
Q4 		$7.05M Buy
428,500
+54,300
+15% +$610K ﹤0.01% 2735
2022
Q3 		$4.78M Buy
374,200
+18,400
+5% +$272K ﹤0.01% 3228
2022
Q2 		$4.16M Buy
355,800
+118,700
+50% +$732K ﹤0.01% 3489
2022
Q1 		$1.44M Sell
237,100
-12,600
-5% -$92.8K ﹤0.01% 6227
2021
Q4 		$2.29M Buy
249,700
+9,600
+4% +$102K ﹤0.01% 5201
2021
Q3 		$2.72M Sell
240,100
-74,300
-24% -$904K ﹤0.01% 5168
2021
Q2 		$3.1M Buy
314,400
+47,300
+18% +$647K ﹤0.01% 4950
2021
Q1 		$3.77M Buy
267,100
+197,400
+283% +$3.19M ﹤0.01% 4467
2020
Q4 		$786K Sell
69,700
-104,000
-60% -$1.23M ﹤0.01% 7257
2020
Q3 		$2.29M Sell
173,700
-238,300
-58% -$4.76M ﹤0.01% 4357
2020
Q2 		$4.41M Buy
412,000
+320,000
+348% +$1.76M ﹤0.01% 3174
2020
Q1 		$295K Buy
+92,000
New +$212K ﹤0.01% 8013
2019
Q3 		– Sell
-12,800
Closed -$30K – 10104
2019
Q2 		$30K Sell
12,800
-34,300
-73% -$91.8K ﹤0.01% 9940
2019
Q1 		$137K Buy
47,100
+31,400
+200% +$93.6K ﹤0.01% 8111
2018
Q4 		$32K Buy
+15,700
New +$55.6K ﹤0.01% 8594
2016
Q3 		– Sell
-97
Closed -$71K – 8348
2016
Q2 		$71K Buy
97
+27
+39% +$18.5K ﹤0.01% 8157
2016
Q1 		$40K Buy
70
+15
+27% +$7.67K ﹤0.01% 8709
2015
Q4 		$31K Buy
+55
New +$27.4K ﹤0.01% 9178
2014
Q3 		– Sell
-37
Closed -$16K – 9375
2014
Q2 		$16K Sell
37
-414
-92% -$187K ﹤0.01% 9689
2014
Q1 		$248K Buy
451
+313
+227% +$183K ﹤0.01% 7899
2013
Q4 		$77K Buy
138
+60
+77% +$35.8K ﹤0.01% 8710
2013
Q3 		$49K Buy
+78
New +$44.7K ﹤0.01% 8239

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Susquehanna International Group's ALT Position: Q1 2026 in Review

Susquehanna International Group reduced its Altimmune (ALT) stake by 3.1% in Q1 2026, selling an estimated $183K and leaving 1,325,956 shares worth $4.08M. The position accounts for ﹤0.01% of the portfolio, ranked #4621.

Susquehanna International Group first reported a position in ALT in Q2 2013 and has held it in 38 quarters since. The position peaked at $14.7M in Q2 2024. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Susquehanna International Group held 1,325,956 shares of Altimmune worth $4.08M as of Q1 2026.
  • Susquehanna International Group sold 43,061 Altimmune shares in Q1 2026, an estimated $183K.
  • Altimmune made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4621 holding.
  • Susquehanna International Group first reported a position in Altimmune in Q2 2013 and has held it in 38 quarters since.
  • Susquehanna International Group's Altimmune position peaked at $14.7M in Q2 2024.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.